Multiple Ascending Dose Trial of BYK324677 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

November 30, 2011

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

BYK324677

capsules, administered orally

Trial Locations (1)

68167

Nycomed Investigational site, Mannheim

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nycomed

INDUSTRY